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Abstract. The evaluation of white matter lesion progression is an im-
portant biomarker in the follow-up of MS patients and plays a crucial
role when deciding the course of treatment. Current automated lesion
segmentation algorithms are susceptible to variability in image char-
acteristics related to MRI scanner or protocol differences. We propose
a model that improves the consistency of MS lesion segmentations in
inter-scanner studies. First, we train a CNN base model to approximate
the performance of icobrain, an FDA-approved clinically available le-
sion segmentation software. A discriminator model is then trained to
predict if two lesion segmentations are based on scans acquired using the
same scanner type or not, achieving a 78% accuracy in this task. Finally,
the base model and the discriminator are trained adversarially on multi-
scanner longitudinal data to improve the inter-scanner consistency of the
base model. The performance of the models is evaluated on an unseen
dataset containing manual delineations. The inter-scanner variability is
evaluated on test-retest data, where the adversarial network produces
improved results over the base model and the FDA-approved solution.
Keywords: Deep learning · inter-scanner · lesion segmentation · adver-
sarial training · longitudinal data · multiple sclerosis
1 Introduction
Multiple sclerosis (MS) is an autoimmune disorder characterized by a demyeli-
nation process which results in neuroaxonal degeneration and the appearance of
lesions in the brain. The most prevalent type of lesions appear hyperintense on
? This project received funding from the European Union’s Horizon 2020 research and
innovation program under the Marie Sklodowska-Curie grant agreement No 765148.
The computational resources and services used were provided by the VSC (Flemish
Supercomputer Center), funded by the Research Foundation Flanders (FWO) and
the Flemish Government department EWI. This work was presented at the MICCAI
BrainLes 2019 workshop and will soon be available as LCNS proceedings.
ar
X
iv
:2
00
2.
00
95
2v
1 
 [e
es
s.I
V]
  3
 Fe
b 2
02
0
2 M. Billast, M. I. Meyer, D. Sima, D. Robben
Fig. 1. MRI scans from one patient in three 3T scanners (left to right: Philips Achieva,
Siemens Skyra and GE Discovery MR750w). Automated lesion segmentations in green.
T2-weighted (T2w) magnetic resonance (MR) images and their quantification is
an important biomarker for the diagnosis and follow-up of the disease [3].
Over the years methods for automated lesion segmentation have been devel-
oped. Several approaches model the distribution of intensities of healthy brain
tissue and define outliers to these distributions as lesions [15,7]. Others are ei-
ther atlas-based [11] or data-driven (supervised) [2,13] classifiers. For a detailed
overview of recent methods refer to [3].
Lesion segmentation is particularly interesting for patient follow-up, where
data from two or more time-points is available for one patient. Some approaches
try to improve segmentation consistency by analysing intensity differences over
time [6]. Although these methods achieve good performance in controlled set-
tings, they remain sensitive to changes in image characteristics related to scanner
type and protocol. In a test-retest multi-scanner study [1], scanner type was ob-
served to have an effect on MS lesion volume. These findings are supported by
[12], where scanner-related biases were found even when using a harmonized
protocol across scanners from the same vendor. Fig. 1 illustrates such an effect.
Few works have addressed the inter-scanner variability issue in the context of
lesion segmentation. Recent approaches attempt to increase the generalization
of CNN-based methods to unseen MR scanner types through domain adaptation
[8] or transfer learning [4,14] techniques. Nevertheless, these methods share the
common downside that they require a training step to adapt to new unseen
domains (scanners types and protocols). The consistency of the delineations in
longitudinal settings is also not considered. A solution to incorporate consistency
information into this type of data-driven solutions would be to train them on
a dataset containing intra- and inter-scanner repetitions for the same patient,
acquired within a short periods of time. However, in practice this type of test-
retest dataset is almost impossible to acquire at a large scale, due to time and
cost considerations.
In the present work we present a novel approach to improve the consistency
of lesion segmentation in the case of multi-scanner studies, by capturing inter-
scanner differences from lesion delineations. Given the shortage of test-retest
data we propose instead to use longitudinal inter-scanner data to train a cross-
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sectional method. We start by training a base model on a multi-scanner dataset
to achieve performance comparable to an existing lesion segmentation software
[7]. We then design a discriminator to identify if two segmentations were gener-
ated from images that originate from the same scanner or not. The assumption
is that the natural temporal variation in lesion shape can be distinguished from
the variation caused by the different scanners. These networks are then combined
and trained until the base model produces segmentations that are similar enough
to fool the discriminator. We hypothesize that through this training scheme the
model will become invariant to scanner differences, thus imposing consistency
on the baseline CNN. Finally we evaluate the accuracy on a dataset with man-
ual lesion segmentations and the reproducibility on a multi-scanner test-retest
dataset.
2 Methods
We start by building a lesion segmentation base model based on a deep convo-
lutional neural network (CNN) architecture [9] that approximates the perfor-
mance of icobrain, an FDA-approved segmentation software. This method is
an Expectation-Maximization (EM) model that uses the distribution of healthy
brain tissue to detect lesions as outliers while also using prior knowledge of the
location and appearance of lesions [7]. We refer to it as EM-model.
Base Model The base model is based on the DeepMedic architecture [9]. Gen-
erally, it is composed of multiple pathways which process different scales of the
original image simultaneously. This is achieved by downsampling the original im-
age at different rates before dividing it into input patches, which allows the model
to combine the high resolution of the original image and the broader context of a
downsampled image to make a more accurate prediction. In our implementation
we used three pathways, for which the input volumes were downsampled with
factors (1, 1, 1), (3, 3, 1) and (5, 5, 3) and divided into patches of size (35, 35, 19),
(25, 25, 19) and (23, 23, 13), respectively. Each pathway is comprised of ten con-
volutional layers, each followed by a PReLu activation, after which the feature
maps from the second and third pathways are upsampled to the same dimen-
sions as the first pathway and concatenated. This is followed by dropout, two
fully connected layers and a sigmoid function, returning a (15, 15, 9) probability
map. The first five layers have 32 filters and kernel size (3,3,1) and the last five
layers 48 filters with kernel size (3,3,3). The values of the output probability
map that are above a certain threshold are classified as lesions. The threshold
used throughout this article is 0.4. The architecture is represented in Fig. 2. The
loss function of the base model is given by
LB = Y log(B(X)) + (1− Y )log(1−B(X)), (1)
where X is the concatenation of the T1- and FLAIR MR images, Y is the corre-
sponding lesion segmentation label and B() the output of the base model.
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Fig. 2. Architecture of the base model that describes the patch sizes of the different
pathways and the overall structure.
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Fig. 3. Architecture of the discriminator that describes the in- and output sizes of the
patches and the overall structure.
Discriminator The discriminator is reduced to one pathway with six convolu-
tional layers, since additional pathways with subsampling resulted in a marginal
increase in performance. The two first layers have 32 filters of kernel size (3,3,1)
and the following layers 48 filters with kernel size (3,3,3). As input it takes two
label patches of size (15, 15, 9) and generates a voxel-wise prediction that the two
labels are derived from images acquired using the same scanner. The architecture
is represented in Fig. 3.
The loss function of the discriminator is given by :
LD = Y log(D(B(X1), B(X2))) + (1− Y )log(1−D(B(X1), B(X2))), (2)
where Y is the ground truth indicator variable (0 or 1) indicating whether two
time points were acquired on the same scanner or not, X1 and X2 are images
at different time points and B() and D() are respectively the output of the base
model and the discriminator.
Adversarial Model After training, the discriminator was combined adversari-
ally with the base model, as introduced in [5]. The adversarial model consists of
two base model blocks (B) and one discriminator (D) (Fig. 4). In our particular
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Fig. 4. Adversarial network that combines the base model and the discriminator to
reduce the inter-scanner variability.
case the pre-trained weights of the discriminator are frozen and only the weights
of the base model are fine-tuned. The concept of adversarial training uses the
pre-trained weights of the discriminator to reduce the inter-scanner variability
of the base model by maximizing the loss function of the discriminator. This is
equivalent to minimizing the following loss function :
LAdv = (1− Y )log(D(B(X1), B(X2))) + Y log(1−D(B(X1), B(X2))), (3)
The loss function of the adversarial network then consists of two terms: one
associated with the lesion segmentation labels, and one related to the output
image of the discriminator:
L = 2 ∗ LB + LAdv (4)
The purpose of LAdv is to ensure that the base model is updated such that the
discriminator can no longer distinguish between segmentations that are based
on same- or different-scanner studies. We hypothesize that the base model learns
to map scans from different scanners to a consistent lesion segmentation.
Model training Both the base model and the discriminator were trained us-
ing the binary cross entropy objective function and optimized using mini-batch
gradient descent with Nesterov momentum β = 0.9. Initial learning rates were
α = 0.016 for the base model and α = 4e−3 for the discriminator, and were de-
creased at regular intervals until convergence. For the adversarial network initial
learning rate was α = 2e−3. All models were trained using an NVIDIA P100. The
networks are implemented using the Keras and DeepVoxNet [10] frameworks.
3 Data and preprocessing
Four different datasets were available: two for training and two for testing
the performance of the models. Since for three of the datasets manual delin-
eations were not available, automated segmentations were acquired using the
EM-method described in the previous section. All automated delineations were
6 M. Billast, M. I. Meyer, D. Sima, D. Robben
validated by a human expert. Each study in the datasets contains T1w and
FLAIR MR images from MS patients.
Cross-sectional dataset 208 independent studies from several centers. The
base model is trained on this dataset.
Longitudinal dataset 576 multi-center, multi-scanner studies with approved
quality MR scans, containing multiple studies from 215 unique patients at dif-
ferent timepoints. For training the adversarial model and the discriminator only
studies with less than 2 years interval were used to minimize the effect of the
natural evolution of lesions over time and capture the differences between scan-
ners. This resulted in approximately 80% being used since most patients have
a follow-up scan every 6 months to one year. The discriminator and adversarial
model are trained on this dataset.
Manual segmentations 20 studies with manual lesion delineations by experts.
Test-retest dataset 10 MS patients. Each patient was scanned twice in three
3T scanners: Philips Achieva, Siemens Skyra and GE Discovery MR450w [7].
All the data was registered to Montreal Neurological Institute (MNI) space
and intensities were normalized to zero mean and unit standard deviation. Ten
studies from each training dataset were randomly selected to use as validation
during the training process. The data was additionally augmented by randomly
flipping individual samples around the x-axis.
4 Results
The models were evaluated on the manual segmentations and the test-retest
datasets described in Section 3 and compared to the EM-model. The main results
are summarized in Table 1. For the manual segmentations dataset results are
described in terms of Dice score, Precision and Recall. For the test-retest dataset
we are mainly interested in evaluating the reproducibility in the inter-scanner
cases. Since there is no ground truth, we report the metrics between different
time points for the same patient. Aside from the total lesion volume (LV) in
mm3 we additionally quantify the absolute differences in lesion volume (|∆LV|)
in mm3. The results in this table were calculated with a lesion threshold value
of 0.4. Fig. 5 depicts the distribution of (|∆LV|) for both inter-scanner and
intra-scanner cases of the test-retest dataset.
Base model For the manual segmentation dataset, results are comparable to
the EM-model. In the test-retest validation, the inter-scanner |∆LV| is larger
for the base model, which indicates that the model is sensitive to inter-scanner
variability.
Discriminator The discriminator is validated on a balanced sample of the
test-retest dataset, so that there is the same number of inter- and intra-scanner
examples. It achieves an accuracy of 78% by looking at the average probability
value on the lesion voxels only.
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Table 1. Mean performance metrics for the different models on two test sets: manual
segmentations and test-retest. For the latter only inter-scanner studies are considered.
|LV| represents absolute differences between individual lesion volumes and is given in
mm3.
Manual Test/Retest
Model Dice Precision Recall |∆LV| LV
EM 0.71± 0.07 0.85 0.61 2077± 2054 8307
Base 0.72± 0.10 0.80 0.65 4557± 3530 9894
Adversarial 0.68± 0.11 0.83 0.59 1331± 1020 8584
0 2000 4000 6000 8000 10000
Absolute difference between same patient repetition scans (| LV|)
Intra-scanner
Inter-scanner
EM-model base adversarial
Fig. 5. Absolute intra- and inter-scanner difference in lesion volume, calculated on the
test-retest dataset with three different models.
Adversarial model On the manual segmentations dataset, again referring to
Table 1, the adversarial model achieves a slightly lower but still competitive
performance when compared to the EM-model.
Regarding the test-retest dataset, the adversarial model produces lower inter-
scanner |∆LV| when compared to the base model (Wilcoxon Signed-Rank Test,
p = 3.26e− 15) and to the EM-model, (Wilcoxon Signed-Rank Test, p = 0.02).
This indicates that the adversarial model produces segmentations that are less
sensitive to inter-scanner variation than both the base model and the EM-model.
The mean |∆LV| values and standard deviation for the EM-model are almost
twice as large as the adversarial model. Taking into account the boxplots in Fig.
5, this is partly explained by the fact that the distribution has a positive skew
and additionally by three significant outliers, which artificially increase the mean
values.
This is evidence that the EM-model has larger variability and lower repro-
ducibility than the adversarial model, while the average predicted lesion volume
is similar for the EM- and adversarial models. Fig. 6 shows an example of the
different lesion segmentations on the different scanners with the three models.
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Fig. 6. Lesion segmentation results for one patient in three 3T scanners. Top: EM-
model; Middle: base model; Bottom: adversarial model. Adversarial model results
appear more consistent, while maintaining physiological meaning.
5 Discussion and future work
We presented a novel approach to improve the consistency of inter-scanner MS
lesion segmentations by using adversarial training on a longitudinal dataset.
The proposed solution shows improvements in terms of reproducibility when
compared to a base CNN model and to an FDA-approved segmentation method
based on an EM approach. The key ingredient in the model is the discriminator,
which predicts with 78% accuracy on unseen data whether two lesion segmen-
tations are based on MRI scans acquired using the same scanner. This is a very
promising result, since this is not a standard problem.
When evaluated on an unseen dataset of cross-sectional data, the model’s per-
formance approximates the EM-model, but decreases slightly after the adversar-
ial training. This indicates a trade-off between performance and reproducibility.
One concern was that this would be connected to an under-segmentation due
to the consistency constraint learned during the adversarial training. However,
evaluating the average predicted lesion volume on a separate test-retest dataset
shows no indication of under-segmentation when compared to the EM-model.
Both the adversarial network and the discriminator were trained on longitu-
dinal inter-scanner data. This is not ideal, since MS can have an unpredictable
evolution over time, and as such it becomes difficult to distinguish between dif-
ferences caused by hardware and the natural progression of the disease. We
attempt to mitigate this effect by selecting studies within no more than two
years interval, but better and more reliable performance could be achieved if the
model would be trained on a large dataset with the same characteristics as the
test-retest dataset described in section 3. However, large datasets of that type
do not exist and would require a very big effort to collect, both from the point
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of view of patients and logistics. As such, using longitudinal inter-scanner data
is a compromise that is cost-efficient and shows interesting results.
Another point that could improve the performance would be to use higher
quality images and unbiased segmentations at training time. This would allow for
a stronger comparison to other methods in literature and manual delineations.
At this moment it is expectable that our model achieves results comparable to
those of the method used to obtain the segmentations it was trained on.
Aside from these compromises, some improvements can still be made in future
work. Namely, during the training and testing stages of the adversarial network
images can be affinely registered to each other instead of using one common atlas
space. We would expect this to increase the overlap metrics. On the other hand
it was observed that the overlap metrics slightly decrease for the adversarial
network with longer training, and as such the weight of the term in the loss
function associated with the discriminator can be optimized/lowered to achieve
more efficient training and better overlap of the images.
Finally, instead of only freezing the weights of the discriminator to improve
the base model, the weights of the base model can also be frozen in a next step to
improve the discriminator, so that the base model and discriminator are trained
in an iterative process until there are no more performance gains.
Apart from the various optimizations to the model, it would be interesting
to apply the same adversarial training to other lesion types, such as the ones
resulting from vascular dementia or traumatic brain injuries.
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